TrialClinical cancer research : an official journal of the American Association for Cancer Research2026
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.
Glenn J Hanna et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.